A three‐lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy

BACKGROUND: Current strategies are insufficient to predict pathologically complete response (pCR) for esophageal squamous cell carcinomas (ESCCs) before treatment. Here, we aim to develop a novel long noncoding RNA (lncRNA) signature for pCR and outcome prediction of ESCCs through a multicenter anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chaoqi, Zhang, Zhihui, Zhang, Guochao, Xue, Liyan, Yang, Haijun, Luo, Yuejun, Zheng, Xiaoli, Zhang, Yonglei, Yuan, Yufen, Lei, Ruixue, Yang, Zhaoyang, Zheng, Bo, Zhang, Zhen, Wang, Le, Che, Yun, Wang, Sihui, Wang, Feng, Fang, Lingling, Zeng, Qingpeng, Li, Jiagen, Gao, Shugeng, Xue, Qi, Sun, Nan, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448795/
https://www.ncbi.nlm.nih.gov/pubmed/32898328
http://dx.doi.org/10.1002/ctm2.156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448795/
https://www.ncbi.nlm.nih.gov/pubmed/32898328
http://dx.doi.org/10.1002/ctm2.156

Ejemplares similares